Showing results (501-510 of 5,531) with videos related to

Sort By:
Pageof 554
Nature|June 7, 2002
Measurement of a confinement induced neutron phaseH Rauch, H Lemmel, M Baron, et al.
Neuropsychobiology|January 1, 1982
Neuroleptic drug effect on plasma dopamine-beta-hydroxylase in schizophreniaM Baron, R Gruen, M Levitt, et al.
Acta Haematologica|January 1, 1994
Hematuria in sickle cell anemia--not always benign: evidence for excess frequency of sickle cell anemia in African Americans with renal cell carcinomaB W Baron, R Mick, J M Baron
Biochemical Society Transactions|October 25, 2007
Mitochondrial dysfunction in neurodegenerative disordersM Baron, A P Kudin, W S Kunz
Seminars in Arthritis and Rheumatism|February 13, 2019
Damage indices in rheumatic diseases: A systematic review of the literatureN Ferdowsi, W Stevens, M Baron, et al.
SAS Journal|March 25, 2015
Benefits of the paraspinal muscle-sparing approach versus the conventional midline approach for posterior nonfusion stabilization: comparative analysis of clinical and functional outcomesNeel Anand, Eli M Baron, Robert S Bray
The American Journal of Psychiatry|August 1, 1985
Familial transmission of schizotypal and borderline personality disordersM Baron, R Gruen, L Asnis, et al.
Annals of the Rheumatic Diseases|September 6, 2008
Lack of association between the interferon-alpha signature and longitudinal changes in disease activity in systemic lupus erythematosusC Landolt-Marticorena, G Bonventi, A Lubovich, et al.
Scandinavian Journal of Rheumatology|May 30, 2020
Impact of immunogenicity on efficacy and tolerability of tumour necrosis factor inhibitors: pooled analysis of biosimilar studies in rheumatoid arthritisP Emery, C-H Suh, M E Weinblatt, et al.
Annals of the Rheumatic Diseases|March 14, 2002
Updated consensus statement on tumour necrosis factor blocking agents for the treatment of rheumatoid arthritis and other rheumatic diseases (April 2001)D E Furst, E C Keystone, F C Breedveld, et al.
Pageof 554